Drug Combination Details
General Information of the Combination (ID: C56091) | |||||
---|---|---|---|---|---|
Name | Paclitaxel NP Info | + | Bcl-2 siRNA Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Brain cancer
[ICD-11: 2A00]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Up-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
|
In-vitro Model | U-138MG | CVCL_0020 | Astrocytoma | Homo sapiens | ||
U-251MG | CVCL_0021 | Astrocytoma | Homo sapiens | |||
Experimental
Result(s) |
A low dose of taxol in combination with a plasmid vector expressing Bcl-2 siRNA effectively induces apoptosis in glioblastoma cells, markedly decreases tumour cell invasion, completely inhibits in vivo angiogenesis, and remarkably suppresses both intracranial and subcutaneous tumour growth in nude mice. |
